Companies / Nautilus Biotechnology, Inc.

Nautilus Biotechnology, Inc.

Nasdaq: NAUTCIK 1808805SEATTLE, WA

Financials

Revenue—
Net income$-59.00M
Total debt—
Cash$14.63M
Diluted EPS$-0.47
Shares outstanding127.3M

Ownership

127.3M shares outstanding · as of Jul 24, 2026
9.9%10%+ / strategic
Ownership
10%+ / strategic9.94%12,653,917
Institutions48.50%61,717,798
Public float41.56%52,883,508

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 15

View all →
Insider% of sharesShares
AH Equity Partners Bio II, L.L.C.10% owner
9.94%12,653,917
Sujal PatelCEOFormerCEO, President, and Secretary · Director · 10% owner
8.15%10,366,721
AH Bio Fund II, L.P.10% owner
——
AH Equity Partners LSV II, L.L.C.10% owner
——
Andreessen Horowitz LSV Fund II, L.P.10% owner
——
Andreessen Marc L10% owner
——
Horowitz Benjamin a10% owner
——
McIlwain Matthew SFormerDirector
——
Mowry AnnaFormerCFO and Treasurer
——
Murphy Matthew B.FormerGeneral Counsel
——

Institutional holders 74

View all →
HolderValue% of shares
Perceptive Advisors LLC$48.87M9.90%
a16z Capital Management, L.L.C.$34.43M13.87%
Cercano Management LLC$13.99M5.64%
Amazon.com Inc$5.65M1.14%
Vanguard Group Inc$5.07M2.04%
BlackRock, Inc.$5.03M2.11%
Millennium Management LLC$4.94M1.00%
Comprehensive Financial Management LLC$4.30M1.73%
Clarius Group, LLC$2.36M0.95%
Geode Capital Management, LLC$2.34M0.47%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 2, 2026AH Equity Partners Bio II, L.L.C.
10% owner
SellCommon Stock$10.85M-4.6M
-28.32%
11,682,032
9.18% of shares
high
Jun 2, 2026AH Equity Partners Bio II, L.L.C.
10% owner
SellCommon Stock$902.5K-384K
-28.32%
971,885
0.76% of shares
medium
Mar 4, 2026Sujal Patel
CEO
BuyCommon Stock$65.2K+25K
+0.24%
10,366,721
8.15% of shares
medium
Jun 18, 2026McIlwain Matthew S
Director
GrantStock Option (Right to Buy)—+45K
45,000
0.04% of shares
low
Jun 18, 2026Nazem Farzad
Director
GrantStock Option (Right to Buy)—+45K
45,000
0.04% of shares
low
Mar 2, 2026Suzuki Kentaro
Executive
GrantStock Option (Right to Buy)—+160K
160,000
0.13% of shares
low
Mar 2, 2026Murphy Matthew B.
Executive
GrantStock Option (Right to Buy)—+160K
160,000
0.13% of shares
low
Mar 2, 2026Parag Mallick
Executive
GrantStock Option (Right to Buy)—+280K
280,000
0.22% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
NAUTCommon StockEquity63909J108BBG00W7G4M12